A boost for US stocks amid hopes of vaccine breakthrough
THE vaccine trade is well and truly on, giving the bull market a double jolt of life and volatility.
US stocks gained last week and the Dow Jones Industrial Average completed its strongest opening in the post-World War II era after promising news emerged from a Covid-19 vaccine trial.
With more updates due from vaccine developer Moderna; the US coping with a rapidly building winter wave of novel coronavirus infections and deaths; and the possibility of another round of emergency stimulus, the coming week is sure to see major moves too.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Novartis to buy radiology specialist Mariana Oncology for US$1 billion
Moderna beats quarterly estimates as cost-cutting pares losses
Weight-loss drugmaker Novo Nordisk's profits soar further
Hugo Boss profit tops expectations, but China lags
DBS customers unable to login to Digibank, PayLah! on Thursday
If inflation continues to build, the Fed won’t be able to maintain neutral stance for long